v3.25.4
PARENT COMPANY ONLY CONDENSED FINANCIAL INFORMATION - Condensed Parent Company Only Statements of Cash Flows (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Cash flows from operating activities:      
Net income $ 25,359 $ 16,090 $ 41,081
Adjustments to reconcile net income to net cash provided by (used in) operating activities:      
Net accretion of securities (454) (763) (844)
Amortization of junior subordinated debentures 639 612 582
Amortization of subordinated notes issuance costs 217 484 878
Stock based compensation 14,013 14,519 13,228
Credit loss expense (benefit) 3,148 18,767 12,203
Change in other assets (6,330) (12,578) (34,450)
Net cash provided by (used in) operating activities 67,065 58,543 60,014
Cash flows from investing activities:      
Proceeds from maturities, calls, and pay downs of securities held to maturity 229 978 529
Net cash provided by (used in) investing activities (525,479) (590,002) (129,509)
Cash flows from financing activities:      
Dividends on preferred stock (3,206) (3,206) (3,206)
Purchase of treasury stock (2,227) (3,292) (81,623)
Proceeds from employee stock purchase plan common stock issuance 2,485 2,184 1,831
Net cash provided by (used in) financing activities 376,768 574,941 (52,052)
Net increase (decrease) in cash and cash equivalents (81,646) 43,482 (121,547)
Cash and cash equivalents at beginning of period 330,117 286,635 408,182
Cash and cash equivalents at end of period 248,471 330,117 286,635
Parent Company      
Cash flows from operating activities:      
Net income 25,359 16,090 41,081
Adjustments to reconcile net income to net cash provided by (used in) operating activities:      
Equity in undistributed subsidiary income (23,384) (3,987) (10,293)
Net accretion of securities (180) (178) (175)
Amortization of junior subordinated debentures 639 612 582
Amortization of subordinated notes issuance costs 217 484 878
Stock based compensation 794 746 719
Credit loss expense (benefit) 277 301 746
Change in other assets (2,543) 61 1,638
Change in accrued expenses and other liabilities (1,428) (2,324) (1,127)
Net cash provided by (used in) operating activities (249) 11,805 34,049
Cash flows from investing activities:      
Investment in subsidiaries (14) 1 (33)
Proceeds from maturities, calls, and pay downs of securities held to maturity 229 978 529
Net cash provided by (used in) investing activities 215 979 496
Cash flows from financing activities:      
Repayment of subordinated notes 0 (39,500) 0
Dividends on preferred stock (3,206) (3,206) (3,206)
Purchase of treasury stock (2,227) (3,292) (81,623)
Stock option exercises 320 413  
Stock option exercises     144
Proceeds from employee stock purchase plan common stock issuance 2,485 2,184 1,831
Net cash provided by (used in) financing activities (2,628) (43,401) (82,854)
Net increase (decrease) in cash and cash equivalents (2,662) (30,617) (48,309)
Cash and cash equivalents at beginning of period 13,412 44,029 92,338
Cash and cash equivalents at end of period $ 10,750 $ 13,412 $ 44,029